Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbamazepine: a bioequivalence study and limited sampling modeling.

G Suarez-Kurtz1, F M Ribeiro, M C Salvadori

  • 1Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil. kurtz@inca.org.br

International Journal of Clinical Pharmacology and Therapeutics
|October 3, 2002
PubMed
Summary

Limited sampling strategy (LSS) models accurately estimate carbamazepine pharmacokinetics, enabling reliable bioequivalence assessment between formulations. This approach simplifies drug analysis while ensuring therapeutic equivalence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Timing performance evaluation of a dual-Axis rotational PET system according to NEMA NU 4-2008 standards: A simulation study.

Biomedical physics & engineering express·2025
Same author

A modified orthogonal-distance ray-tracer method applied to dual rotation PET systems.

Physics in medicine and biology·2025
Same author

Effects of physical exercise on Akkermansia muciniphila: a systematic review of human and animal studies.

Beneficial microbes·2024
Same author

Precise positioning of gamma ray interactions in multiplexed pixelated scintillators using artificial neural networks.

Biomedical physics & engineering express·2024
Same author

A guideline proposal for mice preparation and care in <sup>18</sup>F-FDG PET imaging.

EJNMMI research·2022
Same author

DYNLT1 gene expression is downregulated in whole blood of patients at different Huntington's disease stages.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2020

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Pharmaceutical Sciences
  • Clinical Pharmacology

Background:

  • Carbamazepine is a widely used antiepileptic drug.
  • Assessing bioequivalence of different formulations is crucial for therapeutic interchange.
  • Traditional pharmacokinetic assessments require extensive sampling, which can be burdensome.

Purpose of the Study:

  • To evaluate the bioequivalence of two carbamazepine formulations.
  • To develop and validate limited sampling strategy (LSS) models for estimating key pharmacokinetic parameters: area under the curve (AUC0-infinity) and peak plasma concentration (Cmax).

Main Methods:

  • A randomized, two-sequence, two-period crossover study was conducted in 24 healthy volunteers.
  • Carbamazepine (400 mg) was administered as reference and test conventional-release formulations.

Related Experiment Videos

  • LSS models were developed using a training set and validated on a separate set of subjects.

    • Main Results:

    • Single-point (72h) and two-point (6h, 32h) LSS models accurately predicted carbamazepine's AUC0-infinity and Cmax, respectively (R2 = 0.89-0.95).
    • Bioequivalence assessments using LSS-derived parameters yielded results consistent with traditional methods.
    • The two carbamazepine formulations were determined to be bioequivalent.

    Conclusions:

    • Limited sampling strategy models offer a validated and accurate method for estimating carbamazepine's pharmacokinetic parameters.
    • These LSS models facilitate reliable bioequivalence assessments, potentially reducing the number of blood samples required.
    • The study confirms the bioequivalence of the tested carbamazepine formulations.